Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP074: IL-33 promotes gut mucosal wound healing by inducing miRNA-320 to stimulate epithelial restitution and repairECCO '18 Vienna
Year: 2018
Authors:

L.R. Lopetuso1,2*, C. De Salvo2, L. Di Martino2, N. Rana2, W. Goodman2, F. Scaldaferri1, A. Armuzzi1, A. Gasbarrini1, T.T. Pizarro2

1Catholic University of Sacred Heart, Internal Medicine Department, Gastroenterology Division, Rome, Italy, 2Case Western Reserve University, Pathology, Cleveland, USA

DOP075: Colonic gamma delta t-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

R.J. Dart1,2,3*, P. Vantourout1,2, A. Laing1,2, J. Digby-Bell3, N. Powell3,4, P. Irving3, A. Hayday1,2

1Francis Crick Institute, Immunosurveillance Lab, London, UK, 2King's College London, DIIID, London, UK, 3Guy's and St Thomas Foundation Trust, Department of Gastroenterology, London, UK, 4King's College London, DTIMB, London, UK

DOP076: IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitisECCO '18 Vienna
Year: 2018
Authors:

S. Zundler*, M. Spocinska, V. Popp, E. Becker, R. Atreya, C. Neufert, I. Atreya, B. Weigmann, M.F. Neurath

University of Erlangen-Nuremberg, Department of Medicine I, Erlangen, Germany

DOP077: Deep immunophenotyping reveals a role for Mucosal Associated Invariant T (MAIT) cells in the response to anti-TNF treatment in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

M. Walshe*, L.A. Elliott, D. Danso-Abeam, G. Cullen, J. Sheridan, H. Mulcahy, E. Ryan, G. Doherty

Centre for Colorectal Disease, St. Vincent's University Hospital, Univsersity College Dublin, Dublin, Ireland

DOP078: Visceral and subcutaneous adipose tissues of Crohn’s disease patients contains bacteriaECCO '18 Vienna
Year: 2018
Authors:

C. Serena1*, M. Terrón-Puig1, E. Maymó-Masip1, M. Queipo-Ortuño2, J. Sabadell-Basallote1, M.M. Rodríguez1, C. Nuñez-Roa1, M. Menacho3, E. Espin4, A. Zorzano5,6, M. Millan7, S. Fernández-Veledo1, J. Vendrell1

1Hospital Universitari de Tarragona Joan XXIII. Institut d´Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, Tarragona, Spain, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain, Tarragona, Spain, 2Servicio de Endocrinología y Nutrición, Campus Teatinos s/n, Hospital Clínico Universitario Virgen de la Victoria, 29010, Málaga, Spain, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain, 3Hospital Joan XIII, Digestive Unit, Tarragona, Spain, 4Colorectal Surgery Unit, General Surgery Service, Hospital Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain, 5Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. 6CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Barcelona, Spain. Departamento de Bioquimica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain, 7Hospital Joan XIII, Colorectal Surgery Unit, Tarragona, Spain

DOP079: Heat-shock protein GP96 is essential for self-renewal of the intestinal epithelial barrierECCO '18 Vienna
Year: 2018
Authors:

M. Schwarzfischer1*, Y. Morsy1, K. Atrott1, C. Stanzel1, S. Lang1, G. Rogler1,2, M. Scharl1, M. Spalinger1

1University Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland, 2University Hospital Zurich, Zurich, Switzerland

DOP080: Endoplasmic reticulum stress in bordering epithelium of Crohn’s disease patients with intestinal fibrosisECCO '18 Vienna
Year: 2018
Authors:

S. Hu1*, N. Bletard2, C. Massot1,3, N. Pierre1, F. Quesada Calvo1, G. Paulissen1, N. Smargiasso4, G. Mazzucchelli4, D. Baiwir5, E. De Pauw4, P. Delvenne2, M.-A. Meuwis1,3, E. Louis1,3

1GIGA-R, Uliege, Translational Gastroenterology, Liège, Belgium, 2CHU de Liège, Pathological anatomy, Liège, Belgium, 3CHU de Liège, Hepato-gastroenterology and digestive oncology, Liège, Belgium, 4Uliege,Laboratory of mass spectrometry, Chemistry, Liège, Belgium, 5GIGA proteomic facility, Uliege, GIGA, Liège, Belgium

DOP081: Genital granulomatosis in Crohn’s disease: results of the ECCO CONFER studyECCO '18 Vienna
Year: 2018
Authors:

F. Dederichs1*, I. Iesalnieks2, M. Sladek3, C. Tzivinikos4, R. Hansen5, C. Muñoz6, P. Pavli7, M. Cavicchi8, V. Abitbol9, J.-F. Rahier10, S. Vavricka11, K. Katsanos12, E. Domènech13,14

1Kath. Krankenhaus Hagen, Hagen, Germany, 2Klinikum Bogenhausen, München, Germany, 3Jagiellonian University Medical College, Krakow, Poland, 4Royal London Hospital, London, UK, 5Royal Hospital for Children, Glasgow, UK, 6Villafranca del Hospital Universitario de Basurto, Bilbao, Spain, 7Canberra Hospital, Canberra, Australia, 8Cabinet Medical Créteil, Paris, France, 9Cochin Hospital, Paris, France, 10CHU Dinant-Godinne, Department of Gastroenterology, Yvoir, Belgium, 11Triemli Hospital, Zürich, Switzerland, 12University and Medical School of Ioannina, Ioannina, Greece, 13Hospital Universitari Germans Trias I Pujol, Badalona, Spain, 14CIBEREHD, Madrid, Spain

DOP082: Potential diagnostic biomarkers of ulcerative colitis-associated colorectal dysplasiaECCO '18 Vienna
Year: 2018
Authors:

A.-M. Merli1*, C. Massot1,2, N. Bletard3, F. Quesada Calvo1, D. Baiwir4, G. Mazzucchelli5, N. Smargiasso5, L. Servais6, C. Oury6, M.-C. De Pauw-Gillet7, E. De Pauw5, C. Coimbra Marques8, A. Colard9, A. Vijverman10, P. Delvenne3, M.-A. Meuwis1,2, E. Louis1,2

1GIGA-R, ULiège, Translational Gastroenterology, Liège, Belgium, 2CHU de Liège, Hepato-Gastroenterology and Digestive oncology, Liège, Belgium, 3CHU de Liège, Pathological anatomy and cytology, Liège, Belgium, 4GIGA proteomic facility, ULiège, Liège, Belgium, 5ULiège, Laboratory of mass spectrometry, Chemistry, Liège, Belgium, 6GIGA-R, ULiège, Laboratory of Thrombosis and Hemostasis, Liège, Belgium, 7ULiège, Mammalian cell culture laboratory, Liège, Belgium, 8CHU de Liège, Abdominal Surgery Department, Liège, Belgium, 9CHC de Liège, Gastroenterology, Liège, Belgium, 10CHR Citadelle de Liège, Gastroenterology and Digestive oncology, Liège, Belgium

DOP083: The association of appendectomy and colorectal cancer in ulcerative colitis patients: a systematic review and meta-analysisECCO '18 Vienna
Year: 2018
Authors:

M.E. Stellingwerf*, M.A. de Koning, W.A. Bemelman, G.R. D'Haens, C.J. Buskens

Academic Medical Center (AMC), Department of Surgery, Amsterdam, The Netherlands

DOP084: Toll-interacting protein promotes colitis-associated cancer by regulating immune cell infiltrationECCO '18 Vienna
Year: 2018
Authors:

C. Begka1*, S. Ragusa2, Y. Pu3, C. Mooser4, K. McCoy4, T. Petrova2, M.H. Maillard1

1Service of Gastroenterology and Hepatology, CHUV, University of Lausanne, Lausanne, Switzerland, 2Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland, 3Institute of Pathology, CHUV, Lausanne, Switzerland, 4Clinic for Visceral Surgery and Medicine, Department of Gastroenterology; University Hospital Bern Inselspital, Bern, Switzerland

DOP085: Innate mesenchymal MyD88 signals promote spontaneous intestinal tumorigenesisECCO '18 Vienna
Year: 2018
Authors:

V. Koliaraki1*, A. Henriques1, N. Chalkidi1, A. Polykratis2, M. Pasparakis2, G. Kollias1,3

1BSRC "Alexander Fleming", Vari, Greece, 2University of Cologne, Institute of Genetics, Cologne, Germany, 3University of Athens, School of Medicine, Athens, Greece

DOP086: Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecalibacterium prausnitzii in Quiescent inflammatory bowel disease: a randomised controlled trial and metagenomic analysisECCO '18 Vienna
Year: 2018
Authors:

S. Cox1*, A. Stagg2, S. Fromentin3, D. Ehrlich3,4, N. McCarthy2, N. Galleron3, F. Levenez3, M. Lomer1,5, J. Lindsay2,6, P. Irving7, K. Whelan1

1King's College London, Nutritional Sciences, London, UK, 2Queen Mary University of London, Centre for Immunobiology, London, UK, 3Institut National de la Recherche Agronomique, Microbiology, Paris, France, 4King's College London, Dental Institute, London, UK, 5Guy's and St Thomas' NHS Foundation Trust, Nutrition and dietetics, London, UK, 6Barts Health NHS Trust, Gastroenterology, London, UK, 7Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, UK

DOP087: The gut microbiota of pregnant women with Crohn’s disease and their babies is associated with abnormalities in the adaptive immune system: results from the MECONIUM studyECCO '18 Vienna
Year: 2018
Authors:

J. Torres1,2*, A. Seki3, L. Tarassishin4, J. Hu4, C. Eisele4, N. Nair4, G.J. Britton3,5, Q. Mao4, I. Mogno3,5, J.C. Clemente3,4, J. Faith4, J.-F. Colombel1, S. Mehandru1,3, I. Peter4

1Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, USA, 2Hospital Beatriz Ângelo, Gastroenterology, Loures, Portugal, 3Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York, USA, 4Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, USA, 5Icahn School of Medicine at Mount Sinai, Institute for Genomics and Multiscale Biology, New York, USA

DOP088: Microbial dysbiosis increases experimental colitis by interfering with short-chain fatty acid-dependent mucosal Reg3B expressionECCO '18 Vienna
Year: 2018
Authors:

D. Bajic1, A. Su1, K. Hillmer1, R. Mejias-Luque2, S. Bluemel3, M. Docampo4, R. Schmid1, B. Schnabl3, M. van den Brink4, M. Gerhard2, C. Stein-Thoeringer1,4*

1Klinikum rechts der Isar, II. Med. Klinik, Munich, Germany, 2Institute of Med. Microbiology, TUM, Munich, Germany, 3University of California, San Diego, San Diego, USA, 4Memorial Sloan Kettering Cancer Center, New York, USA

DOP089: Individualised variations in the gut microbiota during remission precede Crohn’s disease flaresECCO '18 Vienna
Year: 2018
Authors:

T. Braun1, A. Di Segni1, S. Neuman1, N. Levhar1, M. Bubis1, O. Picard1, M. BenShoshan1, G. Efroni1, S. Farage Barhom1, E. Glick Saar1, A. Lahad1, D. Shouval1, B. Weiss1, A. Lahat1, R. Eliakim1, S. Ben-Horin1, U. Kopylov1, The Leona M. and Harry B. Helmsley Charitable Trust supported Israeli IBD Research Nucleus (IIRN), Y. Haberman1,2*

1Sheba Medical Center, Tel Hashomer, Israel, 2Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

DOP090: Risk factors for bacteraemia in hospitalised patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

I. Goren1,2*, A. Israel3, A. Brom4, G. Segal4

1Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel, 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Clalit health services, Jerusalem, Israel, 4Sheba Medical Center affiliated with Sackler faculty of medicine Tel Aviv University, Internal Medicine T, Ramat Gan, Israel

N001: Developing a quality of life score for Crohn’s anal fistula (CAF-QoL)ECCO '18 Vienna
Year: 2018
Authors:

S. Adegbola1*, L. Dibley2,3, K. Sahnan1, P. Tozer1,4, N. Yassin1,5, T. Wade2, A. Verjee6, R. Sawyer7, S. Mannick7, P. Lung1,8, R. Phillips1, O. Faiz1,4, J. Warusavitarne1,4, A. Hart1,9, C. Norton2

1St Mark's Academic Institute, Robin Phillip's Fistula Research Unit, London, UK, 2King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 3University of Greenwich, Adult Nursing and Paramedic Science, London, UK, 4St Mark's Hospital, Department of Surgery, London, UK, 5University Hospitals Birmingham, Surgery, Birmingham, UK, 6Homerton University Hospital, Macmillan Cancer Care, London, UK, 7London, London, UK, 8St Mark's Hospital, Department of Radiology, London, UK, 9St Mark's Hospital, Department of IBD, London, UK

N002: A qualitative exploration into experiences of living with Crohn’s anal fistulaECCO '18 Vienna
Year: 2018
Authors:

S. Adegbola1*, L. Dibley2,3, K. Sahnan1, P. Tozer1,4, N. Yassin1,5, T. Wade2, A. Verjee6, R. Sawyer7, S. Mannick7, P. Lung1,8, R. Phillips1, O. Faiz1,4, J. Warusavitarne1,4, A. Hart1,9, C. Norton2

1St Mark's Academic Institute, Robin Phillip's Fistula Research Unit, London, UK, 2King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 3University of Greenwich, Adult Nursing and Paramedic Science, London, UK, 4St Mark's Hospital, Department of Surgery, London, UK, 5University Hospitals Birmingham, Surgery, Birmingham, UK, 6Homerton University Hospital, Macmillan Cancer Care, London, UK, 7London, London, UK, 8St Mark's Hospital, Department of Radiology, London, UK, 9St Mark's Hospital, Department of IBD, London, UK

N003: Can patients schedule own treatment with infliximab (IFX)? A nurse quality control projectECCO '18 Vienna
Year: 2018
Authors:

Anne Berg and Jens Kjeldsen*, A. Berg

Odense Universitets Hospital, Department of Medical Gastroenterology, Odense, Denmark